We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Feather Safety Razor

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Daily Aspirin Regimen Raises Hemorrhage Risk in Elderly

By HospiMedica International staff writers
Posted on 24 Sep 2018
Print article
The use of low-dose aspirin as a primary prevention strategy in older adults results in a significantly higher risk of major hemorrhage, according to a new study.

Researchers at Monash University (Melbourne, Australia), Hennepin Healthcare (Minneapolis, MN, USA), and other institutions conducted a study that enrolled 19,114 community-dwelling men and women in Australia and the United States who were 70 years of age or older, and did not have cardiovascular disease (CVD), dementia, or disability. Participants were randomly assigned to receive 100 mg of enteric-coated aspirin (9,525 people) or placebo (9,589). The primary end point was a composite of death, dementia, or persistent physical disability. Secondary end points included major hemorrhage and CVD.

The results revealed that after a median of 4.7 years of follow-up, the rate of CVD--defined as fatal coronary heart disease, nonfatal myocardial infarction (MI), fatal or nonfatal stroke, or hospitalization for heart failure--was 10.7 events per 1,000 person-years in the aspirin group, and 11.3 events per 1,000 person-years in the placebo group. The rate of major hemorrhage was 8.6 events per 1,000 person-years and 6.2 events per 1,000 person-years, respectively, or 38% higher. The study was published on September 16, 2018, in the New England Journal of Medicine (NEJM).

“The take-home message of such a complex, large, placebo-controlled study is that healthy older people contemplating how best to preserve their health will be unlikely to benefit from aspirin,” said lead author Professor John McNeil, PhD, director of the Monash University department of epidemiology and preventive medicine. “It means millions of healthy older people around the world who are taking low-dose aspirin without a medical reason may be doing so unnecessarily, because the study showed no overall benefit to offset the risk of bleeding.”

Low-dose aspirin is among the most widely used agents for the prevention of CVD. Its efficacy has been established in secondary prevention trials, in which the benefits associated with reducing the rates of both MI and ischemic stroke appear to outweigh the risk of hemorrhage. But the role of low-dose aspirin as a primary prevention strategy remains debated. In elderly populations, the risk of CVD is higher and the potential benefits of aspirin may accordingly be greater than in younger populations; however, an increased risk of bleeding has also been observed in the elderly age group.

Related Links:
Monash University
Hennepin Healthcare


Print article

Channels

Surgical Techniques

view channel
Image: A minimally invasive diagnostic biomarker strategy has proven successful in detecting early esophageal cancer (Photo courtesy of Pexels)

Minimally Invasive Device Combined With Molecular Biomarkers Detects Early Esophageal Cancer

Esophageal cancer remains the sixth-most common cause of cancer death worldwide, claiming the lives of more than half a million people annually. Esophageal squamous cell carcinoma (ESCC) comprises 80%... Read more

Patient Care

view channel
Image: Future wearable health tech could measure gases released from skin (Photo courtesy of Pexels)

Wearable Health Tech Could Measure Gases Released From Skin to Monitor Metabolic Diseases

Most research on measuring human biomarkers, which are measures of a body’s health, rely on electrical signals to sense the chemicals excreted in sweat. But sensors that rely on perspiration often require... Read more

Health IT

view channel
Image: AI can reveal a patient`s heart health (Photo courtesy of Mayo Clinic)

AI Trained for Specific Vocal Biomarkers Could Accurately Predict Coronary Artery Disease

Earlier studies have examined the use of voice analysis for identifying voice markers associated with coronary artery disease (CAD) and heart failure. Other research groups have explored the use of similar... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.